PharmaceuticalIndustry

Prices of more than 3,000 medicines have declined – Health Ministry

The prices of more than 3,000 medicines have decreased since January 1, 2025, including the final price, which now incorporates a EUR 0.75 pharmacist service fee, Parliamentary Secretary of the [..]

Biopharma company to open facility in Vilnius

BioPharmaSpec is a US-based contract research organisation (CRO) which specialises in biopharmaceutical analysis. It has just announced plan to open a new facility in Vilnius, Lithuania, early next year. The [..]

Teva Baltics set to expand its pharmaceutical plant in Vilnius

Teva Baltics, part of Teva Pharmaceutical Industries, one of the world’s largest generic drug manufacturers, is set to expand its pharmaceutical plant in Vilnius with the addition of two new [..]

Government approves new mark-up system for medicines

After two hours of debating, the government on Tuesday approved a new mark-up system for medicines intended to reduce the prices of prescription medicines. At the same time, the government [..]

Olainfarm plans to replace Russia and Belarus with Western markets with new portfolio of medicines

Latvian drug manufacturer JSC Olainfarm plans to replace Russia and Belarus with the Western market with a new portfolio of medicines, Janis Buks, Chairman of the Supervisory Board of the [..]

Turnover of medicines sold by pharmacies up 8.7% in 2023

Last year, the turnover of medicines sold at general pharmacies rose by 8.7 percent against 2022 to EUR 467.073 million (excluding VAT), according to data on pharmacies’ operations released by [..]

Estonians can now purchase prescription medications in Greece

Starting this week, citizens of Estonia and Greece have the ability to use cross-border e-prescription and patient summary services, marking a significant step in the digitalization of healthcare services and [..]

Regulator: Reform has not increased competition in Estonia’s pharmacy market

An analysis by the Estonian Competition Authority shows that the pharmacy reform, which came into force in 2020, has not fulfilled its purpose and has not brought more competition to [..]